Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients undergoing thoracoscopic lobectomy under general anesthesia at a scheduled time; 2.Aged 18-64, of either gender; 3.ASA?~?; 4.BMI 18~30kg/?; 5.Before commencing the trial-related activities, one must fully comprehend, voluntarily participate in the study, willingly sign the informed consent form, and adhere to the trial procedures.
Exclusion criteria
Exclusion criteria: 1.Pregnant or lactating women, as well as women who plan to become pregnant within 3 months; 2.Patients with severe impairments in heart, lung, liver, and kidney functions; 3.Patients with severe neuropsychiatric disorders or cognitive dysfunction; 4.Patients who have been using opioids or psychotropic drugs for a long time; 5.Patients with any drug use contraindications or allergies during the trial; 6.Other situations where researchers believe participation in this trial is not appropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoR-15 score; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of postoperative rescue analgesics required;Kroenke Score;effective pressing frequency of analgesic pump;QoR-15 score;Richmond agitation-sedation scale;VAS of pain scores (at rest/ during coughing); | — |
Countries
China
Contacts
The First People's Hospital of Lianyungang